Cartesian Therapeutics
RNAC
#7549
Rank
NZ$0.50 B
Marketcap
$19.64
Share price
9.10%
Change (1 day)
-10.11%
Change (1 year)

EPS for Cartesian Therapeutics (RNAC)

EPS in 2023 (TTM): -$0.53

According to Cartesian Therapeutics's latest financial reports the company's current EPS (TTM) is -$0.57. In 2021 the company made an earnings per share (EPS) of -$0.43 an increase over its 2020 EPS that were of -$1.23.

EPS history for Cartesian Therapeutics from 2016 to 2023

Annual EPS

Year EPS Change
2023 (TTM)-$0.53
2021-$0.43-65.22%
2020-$1.23-43.44%
2019-$2.17-58.08%
2018-$5.18-9.35%
2017-$5.72-29.16%
2016-$8.07